NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
Combined Company Re-Named NewcelX Ltd., to Commence Trading on the Nasdaq Capital Market on October 31, 2025 under the Ticker Symbol “NCEL” https://mma.prnewswire.com/media/2809532/NewCelX_Logo.jpg NewcelX Ltd. (“NewcelX” or the “Company”) completed the previously announced merger transaction, pursuant to that certain Agreement of Merger and Plan of Reorganization, as amended from time to time, dated as of […]